Skip to main
We’re doing some system maintenance
  1. /
  2. Stocks
  3. /
  4. Aytu BioScience
AYTU

Buy Aytu BioScience (AYTU) Stock

AYTU
See AYTU stock price and Buy/Sell Aytu BioScience with any amount of money. Discuss news and analysts' price predictions with the investor community.
Sign up to start investing
AYTU

Aytu BioScience (AYTU)

About Aytu BioScience (AYTU)

Aytu Biopharma, Inc. is a specialty pharmaceutical company, which focuses on identifying, acquiring, and commercializing novel products. Its products include Adzenys ER, Adzenys XR-ODT, Cotempla XR-ODT, Karbinal ER, Poly-Vi-Flor, Tri-Vi-Flor, Generic Tussionex, Tuzistra XR and ZolpiMist. The company was founded on August 9, 2002 and is headquartered in Englewood, CO.
Market Cap
$11.72M
1 Year High
$3.29
Volume
450.76k
1 Year Low
$0.18
Price to Earnings Ratio
Open
$0.19
Dividend Rate
High
$0.20
Dividend Yield
Low
$0.18

Community

People who own or watch AYTU stock

Aytu BioScience Price Targets

What analysts think AYTU stock price will be.
$0.19
$11
5,751.1% Upside
$0$12

Aytu BioScience Stock Rating

What analysts recommend for AYTU stock, on a scale from 1(buy) to 5(sell).
Strong Buy1 / 5
BuyHoldSell

Aytu BioScience Stock Earnings

The value each AYTU share was expected to gain vs. the value that each AYTU share actually gained.
Expected
Actual

Aytu BioScience Stock News

Frequently Asked Questions (FAQ)

As of Sep 25, 2022, the market cap for AYTU stock is $11.72M

The 52-week high for AYTU stock is $3.29. The current AYTU stock price $0.188 is 94.29% below its 52-week high

The 52-week low for AYTU stock is $0.18. The current AYTU stock price $0.188 has increased 4.26% from its 52-week low

No, the AYTU stock does not pay dividends to its shareholders

The target price for AYTU stock is $11 based on the average of what a group of analyst think AYTU stock could be worth at a future date. This is not a prediction by Public.com

Buy Aytu BioScience (AYTU) Stock

AYTU
See AYTU stock price and Buy/Sell Aytu BioScience with any amount of money. Discuss news and analysts' price predictions with the investor community.
Sign up to start investing

Community

People who own or watch AYTU stock
  • 0tchu avatar
  • shawnabelle avatar
  • NuskiMarley avatar
  • cmeraz avatar
  • Alina760 avatar
Check the background of this firm on FINRA’s BrokerCheck.

© Copyright 2022 Public Holdings, Inc. All Rights Reserved.

Market data powered by Xignite.

Securities are offered to self-directed customers by Open to the Public Investing, Inc. (“Open to the Public Investing”), a registered broker-dealer and member of FINRA & SIPC. Additional information about your broker can be found by clicking here. Open to Public Investing is a wholly-owned subsidiary of Public Holdings Inc. (“Public Holdings”). This is not an offer, solicitation of an offer or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Open to the Public Investing is not registered. Securities products offered by Open to the Public Investing are not FDIC insured.

Cryptocurrency execution and custody services are provided by Apex Crypto LLC (NMLS ID 1828849) through a software licensing agreement between Apex Crypto LLC and Public Crypto LLC. Apex Crypto is not a registered broker-dealer or a member of SIPC or FINRA. Cryptocurrencies are not securities and are not FDIC or SIPC insured. Apex Crypto is licensed to engage in virtual currency business activity by the New York State Department of Financial Services. Please ensure that you fully understand the risks involved before trading: Legal Disclosures

Commission-free trading of stocks and ETFs refers to $0 commissions for Open to the Public Investing self-directed individual cash brokerage accounts that trade the U.S. listed securities electronically. Keep in mind, that other fees such as regulatory fees, Premium subscription fees, wire transfer fees, and paper statement fees may apply to your brokerage account. Please see Open to the Public Investing’s Fee Schedule to learn more.

All investments involve the risk of loss and the past performance of a security or a financial product does not guarantee future results or returns.